Rifabutin triple therapy increased <i>H pylori</i> eradication vs. amoxicillin + omeprazole in treatment-naive patients.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 32926814.
- Also identified by DOI 10.7326/ACPJ202009150-033.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Graham DY, Canaan Y, Maher J, et al. <b>Rifabutin-based triple therapy (RHB-105) for <i>Helicobacter pylori</i> eradication: a double-blind, randomized, controlled trial.</b> Ann Intern Med. 2020;172:795-802. 32365359.
Medical subject headings
- Anti-Ulcer Agents
- Helicobacter Infections
- Helicobacter pylori